Eye drops may halt worsening nearsightedness in adults
NCT ID NCT05850936
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether eye pressure-lowering medication can slow the progression of severe nearsightedness (high myopia) in adults. Researchers will measure changes in eye length and vision over time. The trial includes 152 participants aged 18 to 65 with worsening high myopia and normal eye pressure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH MYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New surgical twist may save sight in babies with rare glaucoma
- Could eye pigment levels predict vision damage in severe nearsightedness?
- Divers' eye pressure spikes during breath-holds, study finds
- Tiny study to check eye pressure after cornea treatment
- Laser or surgery? new study reveals best option for advanced glaucoma
- AI boosts cataract surgery precision for severely nearsighted patients